- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Fortress Biotech Reports Q4 Loss
Biotech firm posts $3.9 million deficit in latest quarter
Mar. 31, 2026 at 9:53pm
Got story updates? Submit your updates here. ›
Fortress Biotech Inc., a pharmaceutical company based in Bay Harbor Island, Florida, reported a loss of $3.9 million in its fourth quarter financial results.
Why it matters
Fortress Biotech is a publicly traded biotech firm focused on developing and commercializing novel pharmaceutical products. Its quarterly earnings reports provide insight into the company's financial health and performance, which is of interest to investors and industry analysts.
The details
In its Q4 2026 report, Fortress Biotech disclosed a net loss of $3.9 million. The company did not provide additional details on the specific factors contributing to the quarterly deficit.
- Fortress Biotech reported its Q4 2026 financial results on March 31, 2026.
The players
Fortress Biotech Inc.
A pharmaceutical company based in Bay Harbor Island, Florida that is focused on developing and commercializing novel drugs.
The takeaway
Fortress Biotech's Q4 2026 financial results indicate the company is facing some financial challenges, though the specific reasons for the $3.9 million loss were not disclosed. Investors and analysts will be closely watching the company's future performance and strategic initiatives to see if it can return to profitability.
